Hillsdale Investment Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-36,200
| Closed | -$2.28M | – | 578 |
|
|
2021
Q2 | $2.28M | Hold |
36,200
| – | – | 0.18% | 154 |
|
|
2021
Q1 | $3.36M | Sell |
36,200
-8,800
| -20% | -$818K | 0.28% | 128 |
|
|
2020
Q4 | $4.03M | Sell |
45,000
-300
| -0.7% | -$26.9K | 0.38% | 82 |
|
|
2020
Q3 | $4.68M | Sell |
45,300
-12,800
| -22% | -$1.32M | 0.46% | 44 |
|
|
2020
Q2 | $4.59M | Sell |
58,100
-2,700
| -4% | -$213K | 0.42% | 48 |
|
|
2020
Q1 | $3.52M | Buy |
+60,800
| New | +$3.52M | 0.42% | 54 |
|
|
2018
Q2 | – | Sell |
-29,900
| Closed | -$1.58M | – | 509 |
|
|
2018
Q1 | $1.58M | Hold |
29,900
| – | – | 0.22% | 63 |
|
|
2017
Q4 | $1.39M | Buy |
+29,900
| New | +$1.39M | 0.22% | 79 |
|